Clinical multi-omics strategies for the effective cancer management

Byong Chul Yoo1, Kyung-Hee Kim2, Sang Myung Woo3

  • 1Biomarker Branch, Research Institute, National Cancer Center, Goyang-si, Gyeonggi-do, Republic of Korea.

Journal of Proteomics
|August 20, 2017
PubMed

Insights

Predictive, preventive, and personalized medicine (PPPM) leverages -omics technologies for integrated cancer diagnosis and treatment. This approach enhances cancer management through data-driven insights and personalized therapeutic strategies.

Area of Science:

  • Oncology
  • Genomics
  • Bioinformatics

Background:

  • Cancer is a complex, multifactorial global health challenge requiring advanced management strategies.
  • Traditional hypothesis-driven research is evolving towards data-driven, untargeted investigations in cancer.
  • Predictive, Preventive, and Personalized Medicine (PPPM) offers a new paradigm for cancer care.

Purpose of the Study:

  • To review the fundamentals and advancements in -omics technologies for cancer.
  • To explore the role of -omics strategies in PPPM for cancer diagnosis and treatment.
  • To provide insights into the application of integrated -omics data for personalized cancer management.

Main Methods:

  • Systematic review of -omics technologies and their applications in PPPM.
  • Discussion of multi-dimensional data integration from various sources.
  • Integration of multidisciplinary -omics strategies with computational methods.

Main Results:

  • -Omics technologies are crucial for data-driven cancer research and personalized medicine.
  • Integration of various -omics data provides novel insights for cancer prognosis and treatment.
  • Combined -omics strategies show significant potential for establishing effective PPPM in oncology.

Conclusions:

  • -Omics technologies are transforming cancer diagnosis, prevention, and treatment.
  • PPPM, powered by -omics, enables more accurate prognosis and tailored therapies.
  • The integration of computational methods with -omics data is key to advancing PPPM for cancer.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Genomics02:02

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
41.1K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
796
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K